Cytokine Gene Polymorphisms in Romanian Multiple Myeloma Patients
Author Information
Author(s): Banu C, Moise A, Arion CV, Coriu D, T̆nase A, Constantinescu I
Primary Institution: National Institute for Medical Assessment and Work Capacity Rehabilitation, Bucharest
Hypothesis
The study aims to determine the cytokine gene polymorphism in Romanian multiple myeloma patients and its correlation with disease evolution and prognosis.
Conclusion
Cytokine gene polymorphisms can serve as reliable individualized prognostic factors in multiple myeloma patients.
Supporting Evidence
- The study identified a significant frequency of certain genotypes in multiple myeloma patients compared to healthy controls.
- Almost one third of patients had the IL–6 pos.–174 GG genotype associated with increased serum levels of IL–6.
- 64% of multiple myeloma patients had the IL–10 GCC haplotype compared to 38% in controls.
Takeaway
The study found that certain gene variations in patients with multiple myeloma can help predict how the disease will progress.
Methodology
Cytokine genotyping was performed in 80 patients and 100 healthy blood donors using molecular biology methods.
Limitations
The study may be limited by the sample size and the specific population studied.
Participant Demographics
Patients included 39 females and 41 males, with a mean age of 59 years (ranging from 36 to 79 years).
Want to read the original?
Access the complete publication on the publisher's website